Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure

Sumit Kar, Lie Gao, Daniel A. Belatti, Pamela L. Curry, Irving H Zucker

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

In chronic heart failure (CHF), arterial baroreflex function is impaired, in part, by activation of the central renin-angiotensin system. A metabolite of angiotensin (Ang) II, Ang-(1-7), has been shown to exhibit cardiovascular effects that are in opposition to that of Ang II. However, the action of Ang-(1-7) on sympathetic outflow and baroreflex function is not well understood, especially in CHF. The aim of this study was to determine the effect of intracerebroventricular infusion of Ang-(1-7) on baroreflex control of heart rate and renal sympathetic nerve activity in conscious rabbits with CHF. We hypothesized that central Ang-(1-7) would improve baroreflex function in CHF. Ang-(1-7) (2 nmol/1 μL per hour) or artificial cerebrospinal fluid (1 μL per hour) was infused by an osmotic minipump for 4 days in sham and pacing-induced CHF rabbits (n=3 to 6 per group). Ang-(1-7) treatment had no effects in sham rabbits but reduced heart rate and increased baroreflex gain (7.4±1.5 versus 2.5±0.4 bpm/mm Hg; P<0.05) in CHF rabbits. The Ang-(1-7) antagonist A779 (8 nmol/1 μL per hour) blocked the improvement in baroreflex gain in CHF. Baroreflex gain increased in CHF+Ang-(1-7) animals when only the vagus was allowed to modulate baroreflex control by acute treatment with the β-1 antagonist metoprolol, indicating increased vagal tone. Baseline renal sympathetic nerve activity was significantly lower, and baroreflex control of renal sympathetic nerve activity was enhanced in CHF rabbits receiving Ang-(1-7). These data suggest that augmentation of central Ang-(1-7) inhibits sympathetic outflow and increases vagal outflow in CHF, thus contributing to enhanced baroreflex gain in this disease state.

Original languageEnglish (US)
Pages (from-to)627-634
Number of pages8
JournalHypertension
Volume58
Issue number4
DOIs
StatePublished - Oct 1 2011

Fingerprint

Baroreflex
Heart Failure
Rabbits
Kidney
7-Ala-angiotensin (1-7)
Heart Rate
angiotensin I (1-7)
Intraventricular Infusions
Metoprolol
Angiotensins
Renin-Angiotensin System
Angiotensin II
Cerebrospinal Fluid

Keywords

  • angiotensin-(1-7)
  • baroreflex
  • blood pressure
  • heart failure
  • heart rate
  • sympathetic nervous system
  • vagus nerve

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure. / Kar, Sumit; Gao, Lie; Belatti, Daniel A.; Curry, Pamela L.; Zucker, Irving H.

In: Hypertension, Vol. 58, No. 4, 01.10.2011, p. 627-634.

Research output: Contribution to journalArticle

Kar, Sumit ; Gao, Lie ; Belatti, Daniel A. ; Curry, Pamela L. ; Zucker, Irving H. / Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure. In: Hypertension. 2011 ; Vol. 58, No. 4. pp. 627-634.
@article{59d53cfe78fc4206b850f323d1fa651e,
title = "Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure",
abstract = "In chronic heart failure (CHF), arterial baroreflex function is impaired, in part, by activation of the central renin-angiotensin system. A metabolite of angiotensin (Ang) II, Ang-(1-7), has been shown to exhibit cardiovascular effects that are in opposition to that of Ang II. However, the action of Ang-(1-7) on sympathetic outflow and baroreflex function is not well understood, especially in CHF. The aim of this study was to determine the effect of intracerebroventricular infusion of Ang-(1-7) on baroreflex control of heart rate and renal sympathetic nerve activity in conscious rabbits with CHF. We hypothesized that central Ang-(1-7) would improve baroreflex function in CHF. Ang-(1-7) (2 nmol/1 μL per hour) or artificial cerebrospinal fluid (1 μL per hour) was infused by an osmotic minipump for 4 days in sham and pacing-induced CHF rabbits (n=3 to 6 per group). Ang-(1-7) treatment had no effects in sham rabbits but reduced heart rate and increased baroreflex gain (7.4±1.5 versus 2.5±0.4 bpm/mm Hg; P<0.05) in CHF rabbits. The Ang-(1-7) antagonist A779 (8 nmol/1 μL per hour) blocked the improvement in baroreflex gain in CHF. Baroreflex gain increased in CHF+Ang-(1-7) animals when only the vagus was allowed to modulate baroreflex control by acute treatment with the β-1 antagonist metoprolol, indicating increased vagal tone. Baseline renal sympathetic nerve activity was significantly lower, and baroreflex control of renal sympathetic nerve activity was enhanced in CHF rabbits receiving Ang-(1-7). These data suggest that augmentation of central Ang-(1-7) inhibits sympathetic outflow and increases vagal outflow in CHF, thus contributing to enhanced baroreflex gain in this disease state.",
keywords = "angiotensin-(1-7), baroreflex, blood pressure, heart failure, heart rate, sympathetic nervous system, vagus nerve",
author = "Sumit Kar and Lie Gao and Belatti, {Daniel A.} and Curry, {Pamela L.} and Zucker, {Irving H}",
year = "2011",
month = "10",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.111.177600",
language = "English (US)",
volume = "58",
pages = "627--634",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure

AU - Kar, Sumit

AU - Gao, Lie

AU - Belatti, Daniel A.

AU - Curry, Pamela L.

AU - Zucker, Irving H

PY - 2011/10/1

Y1 - 2011/10/1

N2 - In chronic heart failure (CHF), arterial baroreflex function is impaired, in part, by activation of the central renin-angiotensin system. A metabolite of angiotensin (Ang) II, Ang-(1-7), has been shown to exhibit cardiovascular effects that are in opposition to that of Ang II. However, the action of Ang-(1-7) on sympathetic outflow and baroreflex function is not well understood, especially in CHF. The aim of this study was to determine the effect of intracerebroventricular infusion of Ang-(1-7) on baroreflex control of heart rate and renal sympathetic nerve activity in conscious rabbits with CHF. We hypothesized that central Ang-(1-7) would improve baroreflex function in CHF. Ang-(1-7) (2 nmol/1 μL per hour) or artificial cerebrospinal fluid (1 μL per hour) was infused by an osmotic minipump for 4 days in sham and pacing-induced CHF rabbits (n=3 to 6 per group). Ang-(1-7) treatment had no effects in sham rabbits but reduced heart rate and increased baroreflex gain (7.4±1.5 versus 2.5±0.4 bpm/mm Hg; P<0.05) in CHF rabbits. The Ang-(1-7) antagonist A779 (8 nmol/1 μL per hour) blocked the improvement in baroreflex gain in CHF. Baroreflex gain increased in CHF+Ang-(1-7) animals when only the vagus was allowed to modulate baroreflex control by acute treatment with the β-1 antagonist metoprolol, indicating increased vagal tone. Baseline renal sympathetic nerve activity was significantly lower, and baroreflex control of renal sympathetic nerve activity was enhanced in CHF rabbits receiving Ang-(1-7). These data suggest that augmentation of central Ang-(1-7) inhibits sympathetic outflow and increases vagal outflow in CHF, thus contributing to enhanced baroreflex gain in this disease state.

AB - In chronic heart failure (CHF), arterial baroreflex function is impaired, in part, by activation of the central renin-angiotensin system. A metabolite of angiotensin (Ang) II, Ang-(1-7), has been shown to exhibit cardiovascular effects that are in opposition to that of Ang II. However, the action of Ang-(1-7) on sympathetic outflow and baroreflex function is not well understood, especially in CHF. The aim of this study was to determine the effect of intracerebroventricular infusion of Ang-(1-7) on baroreflex control of heart rate and renal sympathetic nerve activity in conscious rabbits with CHF. We hypothesized that central Ang-(1-7) would improve baroreflex function in CHF. Ang-(1-7) (2 nmol/1 μL per hour) or artificial cerebrospinal fluid (1 μL per hour) was infused by an osmotic minipump for 4 days in sham and pacing-induced CHF rabbits (n=3 to 6 per group). Ang-(1-7) treatment had no effects in sham rabbits but reduced heart rate and increased baroreflex gain (7.4±1.5 versus 2.5±0.4 bpm/mm Hg; P<0.05) in CHF rabbits. The Ang-(1-7) antagonist A779 (8 nmol/1 μL per hour) blocked the improvement in baroreflex gain in CHF. Baroreflex gain increased in CHF+Ang-(1-7) animals when only the vagus was allowed to modulate baroreflex control by acute treatment with the β-1 antagonist metoprolol, indicating increased vagal tone. Baseline renal sympathetic nerve activity was significantly lower, and baroreflex control of renal sympathetic nerve activity was enhanced in CHF rabbits receiving Ang-(1-7). These data suggest that augmentation of central Ang-(1-7) inhibits sympathetic outflow and increases vagal outflow in CHF, thus contributing to enhanced baroreflex gain in this disease state.

KW - angiotensin-(1-7)

KW - baroreflex

KW - blood pressure

KW - heart failure

KW - heart rate

KW - sympathetic nervous system

KW - vagus nerve

UR - http://www.scopus.com/inward/record.url?scp=80053556070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053556070&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.111.177600

DO - 10.1161/HYPERTENSIONAHA.111.177600

M3 - Article

C2 - 21844487

AN - SCOPUS:80053556070

VL - 58

SP - 627

EP - 634

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 4

ER -